"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
But for people with multiple sclerosis, it can offer clues about something more urgent: whether they can keep driving, ...
WEST PALM BEACH, Fla. -- Paramagnetic rim lesions (PRLs) predicted cognitive decline in multiple sclerosis (MS), data from a longitudinal cohort study showed. At year 4, scores on the Symbol Digit ...
Multiple sclerosis (MS) frequently impairs cognitive function, affecting domains such as information processing speed, memory, attention and executive control. Cognitive assessment in MS integrates ...
The eSDMT enables frequent remote cognitive assessments for pwMS, shifting from cross-sectional to longitudinal evaluation frameworks. The study showed strong concurrent validity and test-retest ...
Patients with multiple sclerosis (MS) showed cognitive improvements with frontal theta-transcranial alternating current stimulation (tACS), suggesting its potential as a tolerable and beneficial ...
In clinical routine, it might be difficult to distinguish between fatigue and depression in Multiple sclerosis (MS). We investigated in two independent observational cohort studies which clinical and ...
SAN DIEGO — Ozanimod was associated with stable or improved cognition in nearly 90% of patients who received the drug for relapsing-remitting multiple sclerosis (RRMS), a new study showed. Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results